Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer.
Jung
K
K
Department of Urology, University Hospital Charité, Humboldt University Berlin, D-10098 Berlin, Germany.
Lein
M
M
von Hösslin
K
K
Brux
B
B
Schnorr
D
D
Loening
S A
SA
Sinha
P
P
D015415:Biomarkers / Q000097:blood; D001859:Bone Neoplasms / Q000175:diagnosis* / Q000556:secondary; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D053244:Osteoprotegerin; D011471:Prostatic Neoplasms / Q000473:pathology*; D018160:Receptors, Cytoplasmic and Nuclear / Q000097:blood*; D018124:Receptors, Tumor Necrosis Factor
D015415:Biomarkers; D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human